Late-Onset Hypogonadism: Liver Disease Risks in Aging American Men
Reading Time: 3 minutes Introduction Late-onset hypogonadism (LOH), characterized by a gradual decline in serum testosterone levels in aging males, affects up to 30% of American men over 60, according to data from the National Health and Nutrition Examination Survey (NHANES). This endocrine disorder manifests with symptoms including fatigue, reduced libido, sarcopenia, and metabolic disturbances, which intersect profoundly with liver health. The liver, pivotal in androgen metabolism via cytochrome P450 enzymes and sex hormone-binding globulin (SHBG) production, becomes a critical nexus in LOH. Emerging evidence links testosterone deficiency to non-alcoholic fatty liver disease (NAFLD), hepatic fibrosis, and cirrhosis risk, exacerbated by America's obesity epidemic—where...


